Abtahi, S., Pajouheshnia, R., Durán, C. E., Gamba, M., Alsina, E., Ibáñez, L., & Riera-Arnau, J. (2023). Impact of 2018 EU Risk Minimisation Measures and Revised Pregnancy Prevention Programme on Utilisation and Prescribing Trends of Medicinal Products Containing Valproate: An Interrupted Time Series Study.
Citación estilo ChicagoAbtahi, Shahab, Romin Pajouheshnia, Carlos E. Durán, Magdalena Gamba, Ema Alsina, Luisa Ibáñez, y Judit Riera-Arnau. Impact of 2018 EU Risk Minimisation Measures and Revised Pregnancy Prevention Programme On Utilisation and Prescribing Trends of Medicinal Products Containing Valproate: An Interrupted Time Series Study. 2023.
Cita MLAAbtahi, Shahab, et al. Impact of 2018 EU Risk Minimisation Measures and Revised Pregnancy Prevention Programme On Utilisation and Prescribing Trends of Medicinal Products Containing Valproate: An Interrupted Time Series Study. 2023.